Brief: Prostatype Genomics: Final Outcome Of Preferential Share Issue
May 16 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* PROSTATYPE GENOMICS AB ANNOUNCES FINAL OUTCOME OF
PREFERENTIAL
SHARE ISSUE
* PREFERENTIAL SHARE ISSUE IS SUBSCRIBED TO APPROXIMATELY 70
PERCENT IN TOTAL, AND PROSTATYPE GENOMICS IS THUS PROVIDED WITH
APPROXIMATELY SEK 24.0 MILLION BEFORE ISSUE COSTS
Source text for Eikon: ID:nWkr47HmCt
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue